The State of Immunity of the Population of the Russian Federation to Rubella during the Elimination of Infection
https://doi.org/10.31631/2073-3046-2024-23-3-38-46
Abstract
Relevance. Serological monitoring of the state of the population's immunity to the rubella virus is one of the key elements of epidemiological surveillance of the infection, which makes it possible to assess the effectiveness of vaccine prevention, including the level of protection of the population from this infection. This article presents a comprehensive analysis of the results of this event in Russia for the period from 2015 to 2022 in individuals vaccinated against this infection, based on data from reports from regional centers and existing statistical models. The aim. To carry out a comprehensive analysis of data on serological monitoring of immunity among indicator groups of the population to rubella virus in the Russian Federation for the period from 2015 to 2022, taking into account the incidence and peculiarities of immunization tactics. Materials and Methods. Serological monitoring was carried out using standardized test systems and techniques, which ensured comparability of data throughout the entire study period (2015-2022). The contingent for the examination was selected with documentary confirmation of the fact of vaccination in the age groups 3–4 years, 9–10, 15–17, 25–29, 30–35 years. Only persons aged 40 years and older were examined without taking into account the vaccination history Results and Discussion. The conducted study confirmed a sufficient, stable level of immunity to the rubella virus in most age groups and regions of the country, which indicates the effectiveness of vaccination and the preservation (stabilization) of the infection elimination process. The slight increase in the average proportion of seronegatives among adults 30–35 and 40 years and older, revealed in the analysis, compared with other groups, requires further observation and clarification of the causes. Conclusions. The study confirmed the high level of immunity to rubella virus among the population of the Russian Federation, which indicates the effectiveness of the current program of vaccination against rubella infection and the infection elimination program. However, groups of the population have been identified, among which there is a slight decrease in the level of immunity, which requires additional attention from health authorities to maintain a stable rubella elimination status in the country. The results of the study will be used as additions to national and regional strategies aimed at maintaining the rubella elimination status.
About the Authors
L. A. BarkinkhoevaRussian Federation
Laura A. Barkinkhoeva – Researcher at the Laboratory for the Prevention of Viral Infections
10, Admiral Makarov Street, Moscow, 125212
+7 (495) 452-18-09
+7 (985) 626-25-19
N. V. Turaeva
Russian Federation
Natalia V. Turaeva – Cand. Sci. (Med.), Head of the Laboratory for the Prevention of Viral Infections
Moscow
+7 (495) 452-18-09
O. V. Tsvirkun
Russian Federation
Olga V. Tsvirkun – Dr. Sci. (Med.), Head of the Epidemiological Department, G. N. Gabrichevsky research institute for epidemiology and microbiology;Associate Professor of the Department of Infectious Diseases of Peoples' Friendship University of Russia named after Patrice Lumumba
Moscow
+7 (495) 452-18-09
A. G. Gerasimova
Russian Federation
Alexandra G. Gerasimova – Cand. Sci. (Med.), Leading Researcher
Moscow
+7 (495) 452-18-09
References
1. Monthly updated report on measles and rubella – WHO European Region – 2024. Available at: www.who.int.
2. Eliminating measures and rubella in the WHO European Region; Integrated guidance for surveillance, outbreak response and verification of elimination. Copenhagen: WHO Regional Office for Europe; 2024. Available at: www.who.int.
3. Tsvirkun O.V., Samoilovich E.O., Tikhonova N.T., et al. State of anti-rubella virus population immunity in the Republic of Belarus and Russian Federation // Russian Journal of Infection and Immunity. 2022;12(5):909–918 (In Russ.). doi: 10.15789/2220-7619-COT-1832
4. Turaeva N.V., Gerasimova A.G., Tsvirkun O.V., et al. Elimination of rubella infection in Russia. // Scientific provision of anti-epidemic protection of the population: current problems and solutions. 2019;115-117 (In Russ.). EDN: JOBDHI.
5. Feldblum I.B., Romanenko V.V., Subbotina K.A.., et al. Safety and immunological efficacy of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaccrivir® during immunization of children 12 months and 6 years old (results of a simple blind multicenter comparative randomized clinical trial). Epidemiology and Vaccine prevention. 2021;20(1):32–43 (In Russ.). doi:10.31631/2073-3046-2021-20-1-32-43
6. Tatochenko V. K., Ozeretskovsky N. A. Immunoprophylaxis 2020. (Reference book). PediatricЪ. Moscow (In Russ.)
7. Measures and rubella strategic framework 2021-2030. URL: www.who.int
8. Chehlyaeva T.S., Tsvirkun O.V., Turaeva N.V., et al. Assessment of the rubella elimination status in the Russian Federation in 2019. Infection and immunity. 2022;12(1):85–94 (In Russ.). doi: 10.15789/2220-7619-ATR-1663.
9. Barkinkhoeva L.A., Turaeva N.V., Tsvirkun O.V., Gerasimova A.G. Topical issues of rubella epidemiology during its elimination. In the book: Modern immunoprophylaxis: challenges, opportunities, prospects. Collection of abstracts of the All-Russian scientific and practical conference with international participation. 2021;14 (In Russ.). EDN: WOEHJJ.
Review
For citations:
Barkinkhoeva L.A., Turaeva N.V., Tsvirkun O.V., Gerasimova A.G. The State of Immunity of the Population of the Russian Federation to Rubella during the Elimination of Infection. Epidemiology and Vaccinal Prevention. 2024;23(3):38-46. (In Russ.) https://doi.org/10.31631/2073-3046-2024-23-3-38-46